Janus Henderson Group’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $221K | Hold |
64,873
| – | – | ﹤0.01% | 2288 |
|
|
2025
Q1 | $260K | Hold |
64,873
| – | – | ﹤0.01% | 2259 |
|
|
2024
Q4 | $421K | Hold |
64,873
| – | – | ﹤0.01% | 2116 |
|
|
2024
Q3 | $359K | Hold |
64,873
| – | – | ﹤0.01% | 2181 |
|
|
2024
Q2 | $361K | Sell |
64,873
-601
| -0.9% | -$3.35K | ﹤0.01% | 2123 |
|
|
2024
Q1 | $438K | Buy |
65,474
+11
| +0% | +$74 | ﹤0.01% | 2070 |
|
|
2023
Q4 | $597K | Buy |
65,463
+32,344
| +98% | +$295K | ﹤0.01% | 1905 |
|
|
2023
Q3 | $182K | Buy |
33,119
+1
| +0% | +$6 | ﹤0.01% | 2409 |
|
|
2023
Q2 | $282K | Buy |
33,118
+120
| +0.4% | +$1.02K | ﹤0.01% | 2281 |
|
|
2023
Q1 | $303K | Buy |
32,998
+16,353
| +98% | +$150K | ﹤0.01% | 2280 |
|
|
2022
Q4 | $170K | Sell |
16,645
-16,647
| -50% | -$170K | ﹤0.01% | 2225 |
|
|
2022
Q3 | $490K | Buy |
33,292
+16,338
| +96% | +$240K | ﹤0.01% | 1965 |
|
|
2022
Q2 | $182K | Sell |
16,954
-118,244
| -87% | -$1.27M | ﹤0.01% | 2338 |
|
|
2022
Q1 | $1.46M | Buy |
+135,198
| New | +$1.46M | ﹤0.01% | 1356 |
|